Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapy Optimization for B-ALL, Burkitt's NHL and High-Grade NHL in Adults
NCT00199082Phase 4Completed
- Start
- Jul 2002
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of doxorubicin, cyclophosphamide, cytarabine, dexamethasone, prednisolone in Burkitt lymphoma (BL), Burkitt leukemia, mediastinal neoplasm, lymphoblastic lymphoma (LL), anaplastic large cell lymphoma (ALCL). Started Jul 2002; status: completed.
02
Drugs
doxorubicincyclophosphamidecytarabinedexamethasoneprednisolone
03
Conditions
Burkitt lymphoma (BL)Burkitt leukemiamediastinal neoplasmlymphoblastic lymphoma (LL)anaplastic large cell lymphoma (ALCL)
Beyond the preview
Go deeper on NCT00199082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00199082.